Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$324,112
+$264,303 QoQ
Shares Held
1,288
+368.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#3,556
of 4,153 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E Fund Management (Hong Kong) Co., Ltd. holds $3,941,164 across 15 Drug Manufacturers - General names. ABBV ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
3,127 | $1,132,349 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,092 | $896,003 | |
| 3 | LLY |
ELI LILLY & Co
|
550 | $659,686 | |
| 4 | JNJ |
Johnson & Johnson
|
2,260 | $573,972 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,288 | $324,112 | |
| 6 | MRK |
Merck & Co., Inc.
|
939 | $120,661 | |
| 7 | PFE |
Pfizer Inc
|
2,154 | $51,868 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
507 | $29,213 |
All Filings in ABBV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,112 | 1,288 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $59,809 | 275 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $11,424 | 50 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,936 | 17 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||